Research Summary
Analyzed using Evidence Intelligence™

Prebiotic fibres do not improve appetite in type 2 diabetes

Last updated September 2, 2026

Key finding

PYY increased significantly after control treatment (P = 0.013).

This study investigated the impact of prebiotic fibers on appetite regulation in individuals with type 2 diabetes, revealing no significant differences in appetite-related hormones or ratings between the interventions.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study investigated the impact of prebiotic fibers on appetite regulation in individuals with type 2 diabetes, revealing no significant differences in appetite-related hormones or ratings between the interventions.

Clinical relevance

Understanding appetite regulation is crucial for managing type 2 diabetes, as it can influence dietary choices and weight management. The findings suggest that while prebiotic fibers may not significantly impact appetite hormones or ratings, further research could explore their potential benefits in other areas of diabetes management.

Keep in mind

The sample size may limit the generalizability of the findings. The study did not assess long-term effects of prebiotic fibers. Potential confounding factors were not fully controlled.

Published in

Journal Reference

Publication details and source links for this paper.

Eline B, Sedegheh G, Kåre IB, Oda KSH, Per MT, Anne-Marie A. The effect of prebiotic fibres on appetite regulation in subjects with type 2 diabetes: a randomized controlled trial. Journal of Nutritional Science. 2021;10:e72. doi:10.1017/jns.2021.70

Main Effects

Ghrelin levels showed no change between treatments (P = 0.71).

Peptide YY levels increased significantly after control treatment (P = 0.013).

Hunger ratings did not differ between treatments (P = 0.366).

Satiety ratings showed no significant difference (P = 0.644).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Inulin-type fructans and Fullness ratings assessed using a visual analogue scale, Ghrelin, Hunger scores, and 3 more.

Primary intervention

Inulin-type fructans

Primary outcomes

  • Fullness ratings assessed using a visual analogue scale
  • Ghrelin
  • Hunger scores

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 59

1

Related topics

6

Evidence pairs

18

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Probiotics and Synbiotics

matched_intervention

Core evidence

Study findings

The primary outcomes reported in this study.

Fullness ratings assessed using a visual analogue scale

Inulin-type fructans → Fullness ratings assessed using a visual analogue scale

Inulin-type fructans → Fullness ratings assessed using a visual analogue scale

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Ghrelin

Inulin-type fructans → Ghrelin

Inulin-type fructans → Ghrelin

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Hunger scores

Inulin-type fructans → Hunger scores

Inulin-type fructans → Hunger scores

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Peptide YY (PYY) levels after RYGB

Inulin-type fructans → Peptide YY (PYY) levels after RYGB

Inulin-type fructans → Peptide YY (PYY) levels after RYGB

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Prospective food consumption ratings

Inulin-type fructans → Prospective food consumption ratings

Inulin-type fructans → Prospective food consumption ratings

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Satiety Ratings

Inulin-type fructans → Satiety Ratings

Inulin-type fructans → Satiety Ratings

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Ghrelin levels remained unchanged (P = 0.71).
  • Control treatment led to a significant increase in peptide YY (P = 0.013).
  • No significant differences in hunger or satiety ratings were observed.
who this applies

Who this applies to

  • Adults diagnosed with type 2 diabetes.
  • Individuals interested in dietary interventions for appetite control.
keep in mind

Keep in Mind

  • Results may not apply to populations outside of the study sample.
  • The short duration of the study limits conclusions about long-term effects.
  • Further research is needed to explore different types of prebiotics.
between the lines

Between the Lines

  • The sample size may limit the generalizability of the findings.
  • The study did not assess long-term effects of prebiotic fibers.
  • Potential confounding factors were not fully controlled.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Probiotics and Synbiotics and Fullness ratings assessed using a visual analogue scale, Probiotics and Synbiotics and Ghrelin.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Inulin-type fructans improve fullness ratings assessed using a visual analogue scale?

Emerging Evidence

Current evidence does not show a clear benefit of Inulin-type fructans for fullness ratings assessed using a visual analogue scale.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Fullness ratings assessed using a visual analogue scale

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Inulin-type fructans improve ghrelin?

Emerging Evidence

Current evidence does not show a clear benefit of Inulin-type fructans for ghrelin.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Ghrelin

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Inulin-type fructans improve hunger scores?

Emerging Evidence

Current evidence does not show a clear benefit of Inulin-type fructans for hunger scores.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Hunger scores

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Inulin-type fructans improve peptide yy (PYY) levels after rygb?

Emerging Evidence

Current evidence does not show a clear benefit of Inulin-type fructans for peptide yy (PYY) levels after rygb.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Peptide YY (PYY) levels after RYGB

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.